IASCX
Price
$12.82
Change
+$1.07 (+9.11%)
Updated
Apr 9 closing price
Net Assets
201.48M
VSCIX
Price
$101.55
Change
+$8.70 (+9.37%)
Updated
Apr 9 closing price
Net Assets
143.36B
Ad is loading...

IASCX vs VSCIX

Header iconIASCX vs VSCIX Comparison
Open Charts IASCX vs VSCIXBanner chart's image
Voya Small Company Port A
Price$12.82
Change+$1.07 (+9.11%)
VolumeN/A
Net Assets201.48M
Vanguard Small Cap Index I
Price$101.55
Change+$8.70 (+9.37%)
VolumeN/A
Net Assets143.36B
IASCX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IASCX vs. VSCIX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IASCX is a Buy and VSCIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 143B vs. IASCX (201M). VSCIX pays higher dividends than IASCX: VSCIX (1.53) vs IASCX (0.55). IASCX was incepted earlier than VSCIX: IASCX (16 years) vs VSCIX (28 years). IASCX (1.45) is less costly to investors than VSCIX (0.04). IASCX is a more actively managed with annual turnover of: 193.00 vs. VSCIX (12.00). IASCX has a lower initial minimum investment than VSCIX: IASCX (0) vs VSCIX (5000000). IASCX annual gain was more profitable for investors over the last year : -12.85 vs. VSCIX (-13.68). VSCIX return over 5 years is better than : 56.55 vs. IASCX (-0.49).
IASCXVSCIXIASCX / VSCIX
Total Expense Ratio1.360.043,400%
Annual Report Gross Expense Ratio1.450.043,625%
Fund Existence16 years28 years-
Gain YTD-18.004-19.28993%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets201M143B0%
Annual Yield % from dividends0.551.5336%
Returns for 1 year-12.85-13.6894%
Returns for 3 years-34.20-5.11670%
Returns for 5 years-0.4956.55-1%
Returns for 10 years-49.7963.61-78%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRPT55.586.28
+12.74%
Sarepta Therapeutics
ADSK263.5324.69
+10.34%
Autodesk
NMFC9.870.76
+8.34%
New Mountain Finance Corp
NODK13.910.39
+2.88%
NI Holdings
ITRM1.120.01
+0.45%
Iterum Therapeutics plc